Taurian MPS (TAURIAN)

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 39.32% indicates strong capital efficiency
• Promoter holding of 63.80% aligns management with minority shareholders
• Sales growth positive at 6.89%, showing some business expansion
• Latest quarter profitable with ₹4 Cr net profit on ₹32 Cr sales
• Price has corrected significantly from ₹440 high, possibly reducing downside

Concerns

• Profit growth is negative at -1.61% despite a P/E of 20.46
• PEG of 2.97 suggests the valuation is expensive relative to growth
• Piotroski F-Score of 4/9 points to weak fundamental health
• No dividend, and insufficient data on book value, debt, and ROE limits full analysis

AI Analysis

At ₹280, Taurian MPS commands a market cap of ₹190 crore, or about 20.5 times trailing earnings. That is not a bargain for a business whose profits fell 1.61% while sales grew only 6.89%. Graham would ask: where is the margin of safety? I don't see it. The ROCE is impressive at 39.32%, suggesting management can deploy capital efficiently, and promoter holding at 63.8% aligns interests. The latest quarter shows sales of ₹32 crore and net profit of ₹4 crore, so the business is functioning. But one quarter is not a trend. The Piotroski F-Score of 4/9 is a warning flag: fundamental health is weak. With a PEG of 2.97, the market is paying nearly three times the growth rate, and there is no dividend to compensate while waiting. The share price has fallen from ₹440 to ₹280, and while that may look like an opportunity, cheapness alone is never enough; the business must also prove its earning power. I would want to understand why profits are stagnant, whether the high ROCE is sustainable, and what the balance sheet truly looks like—data not available here. Until I see consistent growth, prudent capital allocation, and a price that offers a margin of safety, I will keep Taurian MPS on the watch list, not in the portfolio. As Buffett says: 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' Here, I am not sure we have either.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer